Work

Phase II study of bevacizumab plus erlotinib for recurrent malignant gliomas

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.2045

Authors: S. Sathornsumetee, A. Desjardins, J. J. Vredenburgh, J. N. Rich, S. Gururangan, A. H. Friedman, H. S. Friedman, D. A. Reardon

Institution: Duke Medical Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590619980

Cites:

Cited by: 14

Related to: 10